Has Kellie Booth received payments from drug or device companies?

Yes. Drug and device makers reported $2,891 in general payments to Kellie Booth across 168 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kellie Booth did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kellie Booth come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kellie Booth

Psychiatric/Mental Health · Devon, PANPI 1639868458

Payments from drug & device makers

$2,891in general payments, 2019–2025

Across 168 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$686
Neos Therapeutics, LP$570
Corium, LLC$517
Johnson & Johnson$220
Axsome Therapeutics, Inc.$113
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$105
plus $680 from 12 others

What the payments were for

Food & beverage$2,891100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	45	$686
Neos Therapeutics, LP	38	$570
Corium, LLC	33	$517
Johnson & Johnson	6	$220
Axsome Therapeutics, Inc.	5	$113
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	6	$105
E.r. Squibb & Sons, L.L.C.	5	$83
Tris Pharma Inc	5	$83
Otsuka America Pharmaceutical, Inc.	4	$75
Ironshore Pharmaceuticals Inc.	3	$68
Collegium Pharmaceutical, Inc.	3	$64
Bausch Health US, LLC	3	$60
Neurocrine Biosciences, Inc.	3	$56
Alkermes, Inc.	2	$48
Vanda Pharmaceuticals Inc.	2	$43
Supernus Pharmaceuticals, Inc.	2	$39
Teva Pharmaceuticals USA, Inc.	2	$39
Noven Therapeutics, LLC	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,891 in reported general payments places this provider in the 85th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
AtivanLorazepam	12	$14,271
VraylarCariprazine Hcl	13	$11,350
Aripiprazole	13	$2,220
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	12	$364
Escitalopram Oxalate	24	$292
Fluoxetine Hcl	23	$219
Quetiapine Fumarate	15	$107
Clonazepam	11	$79
Lorazepam	20	$37

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$686	$11,35013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Devon

Christine MulliganDevon$16K
Kimberly GarciaAllentown$573K
Cortney SmithWashington$227K
Britney KeplerPittsburgh$158K
Kirstyn KamegBethel Park$136K
Anna DipietroDowningtown$131K
Deena MasciocchiLanghorne$71K
Joseph GagnonChesterbrook$64K
Michelle CohenWashington$62K
Sharon KatzJenkintown$51K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →